Johns Hopkins Institute for NanoBioTechnology
  • About
  • People
    • Core Researchers
    • Associate Researchers
    • Affiliate Researchers
    • Administrative Team
    • Lab Directory
  • Research
    • Engineering for Cancer Therapies
    • Diagnostic Tools Engineered for Early Detection
    • Stem Cells and Regenerative Engineering
    • Process Engineering at the Nanoscale
  • Education
    • Undergraduate Summer Programs
      • Nanobio REU
      • Rosetta Commons REU
    • Masters Industry Co-Op Education Program
    • Past Programs
      • International Research Experience for Students (IRES)
      • Nanotechnology for Cancer Research Fellowship
  • Translation
    • Corporate Partnerships
    • Licensing Opportunities
    • Start-up Companies
    • Translational Research Highlights
  • News
    • News
    • Publications
  • Events
    • The Nano-Bio Symposium
    • The Undergraduate Symposium
    • Calendar
  • Give
  • Resources
  • About
  • People
    • Core Researchers
    • Associate Researchers
    • Affiliate Researchers
    • Administrative Team
    • Lab Directory
  • Research
    • Engineering for Cancer Therapies
    • Diagnostic Tools Engineered for Early Detection
    • Stem Cells and Regenerative Engineering
    • Process Engineering at the Nanoscale
  • Education
    • Undergraduate Summer Programs
      • Nanobio REU
      • Rosetta Commons REU
    • Masters Industry Co-Op Education Program
    • Past Programs
      • International Research Experience for Students (IRES)
      • Nanotechnology for Cancer Research Fellowship
  • Translation
    • Corporate Partnerships
    • Licensing Opportunities
    • Start-up Companies
    • Translational Research Highlights
  • News
    • News
    • Publications
  • Events
    • The Nano-Bio Symposium
    • The Undergraduate Symposium
    • Calendar
  • Give
  • Resources
    • Stem Cells and Regenerative Engineering
    • Translational Research

    Nano-sized Magnetic Artificial Cells for Cancer Immunotherapy and Diagnosis

    October 10, 2017

    A recently published study by an INBT research team from the labs of Hai-Quan Mao and Jonathan Schneck at the Johns Hopkins School of Medicine, shows that their design of new nano-sized artificial cells is effective at activating T cells, specialized immune cells, to destroy damaged and infected cells, as well as destroying cancer cells. Read More

    • Engineering for Cancer Therapies
    • Stem Cells and Regenerative Engineering

    How old are your cells? New method determines cell age more accurately

    July 12, 2017

    Sure, you know how old you are, but what about your cells? Are they the same age? Are they older, younger? Why does it matter? Led by scientists at Johns Hopkins… Read More

    • Engineering for Cancer Therapies
    • Stem Cells and Regenerative Engineering

    Combo treatment harnesses immune system to fight skin cancer

    June 14, 2017

    By combining two treatment strategies, both aimed at boosting the immune system’s killer T cells, Johns Hopkins researchers report they lengthened the lives of mice with skin cancer more than by using either strategy on its own. And, they say, because the combination technique is easily tailored to different types of cancer, their findings — if confirmed in humans — have the potential to enhance treatment options for a wide variety of cancer patients. Read More

    • Diagnostic Tools Engineered for Early Detection
    • Event
    • Stem Cells and Regenerative Engineering
    • Translational Research

    Highlights of the 11th Annual Nano-Bio Symposium, Engineering Vascularization

    May 14, 2017

    Blood vessels play a dual role in healing as well as spreading diseases in the body. While vascular systems carry vital nutrients, they are also a pathway for malignancies to infiltrate other body systems. The challenge for researchers is encouraging blood vessel formation in one instance, while inhibiting formation in another. Such was the theme of the 11th annual Johns Hopkins Nano-Bio Symposium, Engineering Vascularization, on Friday, May 5, 2017 at the Johns Hopkins School of Medicine. The symposium was jointly organized by Johns Hopkins Institute for NanoBioTechnology (INBT) and Physical Sciences-Oncology Center (PS-OC). Read More

Newer posts 1 2 3

Johns Hopkins Institute for NanoBioTechnology

3400 North Charles
Croft Hall 100
Baltimore, MD 21218

Phone | 410-516-5634
Fax      | 410-516-2355
Email  | inbt@jhu.edu

Privacy Statement

© Johns Hopkins Institute for NanoBioTechnology. All Rights Reserved. | admin
Site by Pendari